Report Status: Final Quest @) Diagnostics EPSTEIN, JEFFREY | Patient Information Specimen Information Client Information EPSTEIN, JEFFREY Specimen: MR624132A Client #: 78300020 56W5265 Requisition: 0002759 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 64 BRUCE MOSKOWITZ, MD Gender: M Attn: NATIONWIDE ACCOUNT Phone: 561.366.0084 Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name LIPID PANEL CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL Collected: 08/09/2017 Received: 08/14/2017 / 08:51 EDT Reported: 08/14/2017 / 08:51 EDT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Out Of Range Reference Range Lab In Range 211 8 125-200 mg/dL MI 25 L > OR = 40 mg/dL MI 532 H <150 mg/dL MI <130 mg/dL (calc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 8.4 H NON HDL CHOLESTEROL 186 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.8 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 Years: hs-CRP mg/L Risk According to AHA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, may be associated with infection and inflammation. HOMOCYSTEINE 15.448 Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. < OR = 5.0 (calc) MI mg/dL (calc) MI mg/L TP <11.4 umol/L MI COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 94 65-99 mg/dL Fasting reference interval UREA NITROGEN (BUN) 19 7-25 mg/dL CREATININE 1.06 0.70-1.25 mg/dL For patients >49 years of age, the reference limit CLIENT SERVICES: 866.697.8378 SPECIMEN: MR624132A PAGE | OF 5 Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621382

--=PAGE_BREAK=--

e@ Quest Report Status: Final ©! Diagnostics EPSTEIN, JEFFREY | Patient Information | Specimen Information | Client Information EPSTEIN, JEFFREY Specimen: MR624132A Client #: 78300020 Collected: 08/09/2017 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 64 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Received: 08/14/2017 / 08:51 EDT Reported: 08/14/2017 / 08:51 EDT Test Name eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT HEMOGLOBIN Alc In Range 74 86 NOT APPLICABLE 5.78 For someone without known diabetes, a hemoglobin Alc value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Alc targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID 6.9 Therapeutic target for gout patients: <6.0 mg/dL TSH T4 (THYROXINE), TOTAL FREE T4 INDEX (T7) T3 UPTAKE SED RATE BY MODIFIED WESTERGREN CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT RED BLOOD CELL COUNT HEMOGLOBIN HEMATOCRIT MCV MCH MCHC ROW PLATELET COUNT CLIENT SERVICES: 866.697.8378 SPECIMEN: MR624132A Out Of Range for Creatinine is approximately 13% higher for people identified as African-American. Reference Range Lab > OR 60 mL/min/1.73m2 > OR 60 mL/min/1.73m2 6-22 (calc) 135-146 mmol/L 3.5-5.3 mmol/L 98-110 mmol/L 20-31 mmol/L .6-10.3 mg/dL -1-8.1 g/dL -5.1 g/dL -3.7 g/dL (calc) -2.5 (calc) .2-1.2 mg/dL 40-115 U/L 10-35 U/L 9-46 U/L <5.7 % of total Hgb MI Orr WHA own 4.0-8.0 mg/dL MI 0.40-4.50 mIU/L MI 4.5-12.0 mcg/dL MI 1.4-3.8 22-35 % MI MI < OR = 20 mm/h MI 3.8-10.8 Thousand/uL 4.20-5.80 Million/uL 13.2-17.1 g/dL 38.5-50.0 % 80.0-100.0 fL 27.0-33.0 pg 32.0-36.0 g/dL 11.0-15.0 % 140-400 Thousand/uL PAGE 2 OF 5 Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621383

--=PAGE_BREAK=--

Report Status: Final Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. (@) Quest Be) Disonostics EPSTEIN, JEFFREY Patient Information | Specimen Information | Client Information | EPSTEIN, JEFFREY Specimen: MR624132A Client #: 78300020 Collected: 08/09/2017 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 64 Received: 08/14/2017 / 08:51 EDT Gender: M Reported: 08/14/2017 / 08:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab MPV 9.7 7.5-12.5 fL ABSOLUTE NEUTROPHILS 2664 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2304 850-3900 cells/uL ABSOLUTE MONOCYTES 510 200-950 cells/uL ABSOLUTE EOSINOPHILS 450 15-500 cells/uL ABSOLUTE BASOPHILS 72 0-200 cells/uL NEUTROPHILS 44.4 % LYMPHOCYTES 38.4 % MONOCYTES 8.5 % EOSINOPHILS 7.5 % BASOPHILS 1.2 3 URINALYSIS, COMPLETE MI See Endnote 1 VITAMIN B12 439 200-1100 pg/mL MI C-REACTIVE PROTEIN 0.12 <0.80 mg/dL MI Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. CORTISOL, TOTAL 20 meg/dL MI Reference Range: For 8 ~ (7-9 -) Specimen: 4.0-22.0 Reference Range: For 4 (3-5 -) Specimen: 3.0-17.0 * Please interpret above results accordingly * TESTOSTERONE, TOTAL MI MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 197 L 250-827 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly less than approximately 300 ng/dL may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in red-top tube with no gel. Two morning (8-10 +) specimens obtained on different days are recommended by The Endocrine Society for screening for hypogonadism. PSA, TOTAL 0.5 < OR = 4.0 ng/mL MI The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. Endnote 1 EEE EERE EEE EEE EEE EERE EERE EERE * Test not performed. * CLIENT SERVICES: 866.697.8378 SPECIMEN: MR624132A PAGE 3 OF 5 EFTA00621384

--=PAGE_BREAK=--

Diagnostics” @ ) Quest Report Status: Final EPSTEIN, JEFFREY Patient Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 64 Gender: M Patient ID; 19530120MJE Health ID: 857300329085 1249 * No urine received. _ Specimen Information Specimen: MR624132A Collected: 08/09/2017 Received: 08/14/2017 / 08:51 EDT Reported: 08/14/2017 / 08:51 EDT * TERRE E ERR EERE EERE EEE EEE RR EEE EH CLIENT SERVICES: 866.697.8378 SPECIMEN: MR624132A | Client Information Client #: 78300020 MOSKOWITZ, BRUCE W PAGE 4 OF 5 Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621385

--=PAGE_BREAK=--

Report Status: Final (@ ) Quest Diagnostics” EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY Specimen: MR624132A Client #: 78300020 Collected: 08/09/2017 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 64 Received: 08/14/2017 / 08:51 EDT Gender: M Reported: 08/14/2017 / 08:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Endocrinology Test Name Result Reference Range Lab VITAMIN D,25-OH, TOTAL,IA 35 30-100 ng/mL MI Vitamin D Status 25-OH Vitamin D: Deficiency: <20 ng/mL Insufficiency: 20 - 29 ng/mL Optimal: > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD (TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this — = to: (This link is being provided for informational/educational purposes only.) Physician Comments: PERFORMING SITE: MI QUEST DIAGNOSTICS-MIAMI, 10200 COMMERCE PARKWAY, MIRAMAR, FL 33025.3938 Laboratory Director: GLEN L. HORTIN MD PHD, CLIA: 10D0277334 TP QUEST DIAGNOSTICS-TAMPA, 4225 E FOWLER AVE, TAMPA, FL 33617-2026 Laboratory Director: GLEN L HORTIN.MD-PHD, CLIA: 10D0291 120 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR624132A PAGE 5 OF 5 Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621386